NCT03235778View on ClinicalTrials.gov

A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

March 19, 2018

Study Completion Date

June 15, 2018

Conditions
Healthy
Interventions
DRUG

Felbinac Trometamol Injection

Felbinac Trometamol Injection will be infused IV as a single dose in 100 mL normal saline,in a 30-minute period using a programmable pump

DRUG

Placebo

Normal saline will be infused IV as a single dose in 100 mL normal saline,in a 30-minute period using a programmable pump

Trial Locations (1)

130021

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Yiling Pharmaceutical Inc.

INDUSTRY

NCT03235778 - A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Biotech Hunter | Biotech Hunter